Top Markets
#1 0G 0G +42.29%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.97%
#3 StonkBroker StonkBroker +36.41%
#4 Useless Coin Useless Coin +35.87%
#5 SAFEcoin SAFEcoin +29.71%
#6 Zora Zora +27.85%
#7 rsERG rsERG +23.63%
#8 Dogs Dogs +23.41%
#9 ICON ICON +21.91%
#10 Notcoin Notcoin +18.12%
Coin of the day
0G 0G
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
TransThera Sciences (Nanjing). Inc. TransThera Sciences (Nanjing). Inc.

TransThera Sciences (Nanjing). Inc.

2617
Peringkat dalam Saham #13137
TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company,... TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases. The company provides Tinengotinib (TT-00420), a MTK inhibitor that is in clinical stage for the treatment of recurrent or refractory drug-resistant solid tumors. It also develops TT-00973, a kinase inhibitor for treating various cancers; TT-01488, a BTK inhibitor for the treatment of B-cell lymphoma; TT-01688, an oral S1P1 modulator for treating various inflammatory diseases; TT-00920, an oral PDE9 inhibitor used for treating central nervous system diseases; TT-01025, an oral irreversible VAP-1 inhibitor designed for the treatment of NASH; and TT-02332, a NLRP3 inhibitor for metabolic and inflammatory diseases. The company has a collaboration with Neurocrine Biosciences, Inc. to develop NLRP3 inhibitors for multiple disease. TransThera Sciences (Nanjing), Inc. was formerly known as Nanjing TransThera Biosciences Co. Ltd. and changed its name to TransThera Sciences (Nanjing), Inc. in July 2021. The company was incorporated in 2014 and is headquartered in Nanjing, China.
Harga Saham
$1.30
Kapitalisasi Pasar
$516.38M
Perubahan (1 hari)
-2.21%
Perubahan (1 tahun)
-81.27%
Negara
CN
Perdagangan TransThera Sciences (Nanjing). Inc. (2617)

Kategori

Healthcare
Riwayat dividen untuk TransThera Sciences (Nanjing). Inc. (2617)
Saham TransThera Sciences (Nanjing). Inc. (simbol: 2617) telah membayar total 0 dividen.
Total semua dividen (disesuaikan dengan stock split): 0.00
Imbal hasil dividen (TTM): 0
Pembayaran dividen untuk TransThera Sciences (Nanjing). Inc. (2617) dari 2026 hingga 2026
Pembayaran dividen tahunan
Tahun Dividen (disesuaikan dengan stock split) Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Daftar semua pembayaran dividen
Tahun Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Pembayaran dividen untuk perusahaan sejenis atau pesaing
Perusahaan Jumlah pembayaran dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH